NCPA applauds lawmakers’ pursuit of MAC pricing transparency
ALEXANDRIA, Va. — Eleven congressmen have asked the Centers for Medicare & Medicaid Services (CMS) for information on the enforcement of transparency measures for generic drug payments in Medicare Part D plans for 2016. The National Community Pharmacists Association said Thursday that this week U.S. Reps. Rick Allen (R., Ga.), Rod Blum (R., Iowa), Buddy
